statistiche ricercatore

Continente	#
EU - Europa	549
NA - Nord America	531
AS - Asia	419
SA - Sud America	44
AF - Africa	16
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.560

Nazione	#
US - Stati Uniti d'America	520
CN - Cina	160
GB - Regno Unito	142
SG - Singapore	137
DE - Germania	104
SE - Svezia	71
IT - Italia	60
IE - Irlanda	43
RU - Federazione Russa	36
UA - Ucraina	33
IN - India	29
TR - Turchia	28
BR - Brasile	24
EU - Europa	20
KR - Corea	19
HK - Hong Kong	18
VN - Vietnam	16
FI - Finlandia	15
NL - Olanda	15
FR - Francia	14
CI - Costa d'Avorio	10
CO - Colombia	8
CA - Canada	6
GR - Grecia	6
AR - Argentina	5
UZ - Uzbekistan	4
CZ - Repubblica Ceca	3
JP - Giappone	3
MX - Messico	3
BE - Belgio	2
EC - Ecuador	2
EG - Egitto	2
PY - Paraguay	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BS - Bahamas	1
CH - Svizzera	1
CV - Capo Verde	1
DK - Danimarca	1
GM - Gambi	1
KE - Kenya	1
KH - Cambogia	1
KW - Kuwait	1
LT - Lituania	1
PE - Perù	1
PK - Pakistan	1
PL - Polonia	1
PS - Palestinian Territory	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	1.580

Nome	#
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments	236
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy	189
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre	166
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab	165
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis	162
Juvenile idiopathic arthritis in adulthood : evaluation of disease activity, damage and quality of life	160
Chronic Recurrent Multifocal Osteomyelitis (CRMO) : four cases treated with Aminobisphosphonate (Pamidronate)	154
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients	144
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study	141
Rituximab in juvenile idiopathic arthritis (JIA)non responsive to anti-TNF : experience of 14 patients treated	126
Totale	1.643

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	88	0	0	0	0	0	0	9	8	19	7	37	8
2021/2022	70	9	0	0	1	6	3	12	5	9	4	6	15
2022/2023	149	16	11	7	33	14	36	0	10	15	1	5	1
2023/2024	89	1	8	10	4	18	14	5	5	0	2	10	12
2024/2025	267	6	32	0	45	25	7	6	22	16	14	19	75
2025/2026	299	74	28	44	40	62	25	26	0	0	0	0	0
Totale													1.643

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca